|
MAGI3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.958400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.461200E-03 |
| Normal-vs-Stage2 |
5.169200E-01 |
| Normal-vs-Stage3 |
3.897800E-03 |
| Normal-vs-Stage4 |
1.420440E-01 |
| Stage1-vs-Stage2 |
2.104300E-02 |
| Stage1-vs-Stage3 |
5.395000E-01 |
| Stage1-vs-Stage4 |
9.650600E-01 |
| Stage2-vs-Stage3 |
1.358420E-02 |
| Stage2-vs-Stage4 |
9.517900E-02 |
| Stage3-vs-Stage4 |
7.180400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.443430E-03 |
| Normal-vs-AfricanAmerican |
6.039800E-01 |
| Normal-vs-Asian |
1.130060E-02 |
| Caucasian-vs-AfricanAmerican |
9.323600E-02 |
| Caucasian-vs-Asian |
6.754800E-01 |
| AfricanAmerican-vs-Asian |
7.760200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.866100E-02 |
| Normal-vs-Female |
8.202100E-03 |
| Male-vs-Female |
9.328600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.662920E-03 |
| Normal-vs-Age(41-60Yrs) |
5.183700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.986190E-01 |
| Normal-vs-Age(81-100Yrs) |
2.570000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.302600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.412010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.460200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.904400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.307200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.304200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.316200E-03 |
| Classical-VS-Follicular |
1.96160000021095E-07 |
| Classical-VS-Other |
4.092400E-01 |
| Classical-VS-Normal |
1.626600E-04 |
| Tall-VS-Follicular |
6.42309982978873E-10 |
| Tall-VS-Other |
1.803620E-01 |
| Tall-VS-Normal |
8.02770000030151E-07 |
| Follicular-VS-Other |
4.463600E-01 |
| Follicular-VS-Normal |
2.329700E-02 |
| Other-VS-Normal |
9.876000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.778600E-01 |
| Normal-vs-N1 |
7.95130000000865E-05 |
| N0-vs-N1 |
1.241550E-03 |
|
|
